The cellular distribution and nature of proteoglycans synthesised by human breast cancer cells in culture were studied. Proteoglycans were labelled with [ 35 S] sulfate, purified, and characterised after ion-exchange chromatography followed by gel-filtration chromatography and treatment with glycosa
Production of PDGF-like growth factor by breast cancer cell lines
โ Scribed by Enrique Rozengurt; James Sinnett-Smith; Joyce Taylor-Papadimitriou
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- French
- Weight
- 677 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The breast cancer cell line T47D produces factors which show mitogenic activity for 3T3 cells. Here we describe the partial purification of one of these factors and show that it has properties similar to plateletderived growth factor (PDGF). The T47D factor is a heatโstable hydrophobic protein with a molecular weight of around 30,000, which inhibits the binding of ^125^IโEGF in a temperatureโdependent manner. This 30 kd protein does not act synergistically with PDGF or fibroblastโderived growth factor (FDGF; also PDGFโlike) in stimulating DNA synthesis; moreover, like these two factors, its mitogenic activity can be inhibited by an antiserum raised against human PDGF. A PDGFโlike growth factor was also found in the serum free medium of the breast cancer cell line MDAโMB157. Since PDGF acts on mesenchymal cells, the production of PDGF like growth factors by breast cancer cells suggests a basis for the intense stromal reaction seen in human breast cancers.
๐ SIMILAR VOLUMES
The mitogenic effects of insulin-like growth factors (IGFs) are regulated by a family of insulin-like growth factor binding proteins (IGFBPs). One member of this family, IGFBP-3, mediates the growth-inhibitory and apoptosis-inducing effects of a number of growth factors and hormones such as transfor
The secretion of insulin-like growth-factor-binding proteins (IGFBPs) and expression of the genes encoding IGFBP-I, IGFBP-2 and IGFBP-3 have been studied in a panel of cell lines derived from breast carcinomas, Wilms' tumour, neuroblastoma, retinoblastoma, colon carcinoma, liver adenocarcinoma, Burk
The present study was carried out to determine if an insulin-like growth factor (IGF) type activity might be produced by embryonal carcinoma-derived cells. The cell line used to condition growth medium for the isolation of secreted growth factors was a newly established Dif 5 cell type. Dif 5 cells